Reimbursing new technologies: why are the courts judging experimental medicine?
Saver
R S
RS
Stanford Law School.
D016026:Bone Marrow Transplantation / Q000191:economics; D002986:Clinical Trials as Topic / Q000191:economics; D032921:Consensus; D032982:Contracts; D004059:Diffusion of Innovation; D035082:Federal Government; D033161:Government Regulation; D015276:Health Care Rationing / Q000191:economics; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D033222:Judicial Role; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D012106:Research / Q000191:economics*; D018570:Risk Assessment; D013673:Technology Assessment, Biomedical / Q000191:economics* / Q000331:legislation & jurisprudence; D036302:Therapeutic Human Experimentation; D035501:Uncertainty; D014481:United States; D014486:United States Food and Drug Administration